✦ LIBER ✦

Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses

✍ Scribed by M. Luyckx; J. L. Cazin; C. Brunet; P. Gosselin; M. C. Demaille

Publisher: Springer
Year: 1985
Tongue: English
Weight: 715 KB
Volume: 28
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00544367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of high-dose etoposide

Pharmacokinetics of high-dose etoposide after short-term infusion

✍ P. Köhl; H. Köppler; L. Schmidt; H. W. Fritsch; J. Holz; K. H. Pflüger; H. Jungc 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 440 KB

Pharmacokinetic modeling of plasma and c

Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children

✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine

Renal excretion and pharmacokinetics of

Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children

✍ B. Winograd; R. J. J. Lippens; M. J. M. Oosterbaan; M. J. M. Dirks; T. B. Vree; 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 782 KB

Degradation and clearance of methotrexat

Degradation and clearance of methotrexate in children with osteosarcoma receiving high-dose infusion

✍ Wang, Yeu-Ming ;Kim, Pyong-Young ;Lantin, Erlinda ;van Eys, D. Catherine ;Romsda 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

## Abstract Plasma methotrexate (MTX) concentrations were quantitated in 34 patients after 127 high‐dose (35–350 mg/kg) infusions with citrovorum factor rescue. Significant linear correlations have been obtained between methotrexate dosage and concentrations in plasma at 6 and 24 hours after the in

Thirty-six-hour preoperative high-dose m

Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neck

✍ Hande, K. R. ;Chretien, P. B. ;Elias, E. G. ;Goldberg, N. H. ;Brooks, A. E. ;Cha 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Twenty 36-hour infusions of high-dose methotrexate were given preoperatively to 10 patients with head and neck cancer. Plasma methotrexate levels of greater than 1 X 10(-5) M were maintained for 36 hours and declined with primary and secondary plasma half-lives of 1.7 and 9.2 hours following the end

Pharmacokinetics and toxicity of high-do

Pharmacokinetics and toxicity of high-dose human α1-acid glycoprotein infusion in the rat

✍ D. E. Keyler; P. R. Pentel; D. B. Haughey 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB